Dispersol Technologies LLC — Pharmaceutical Company, Georgetown

Pharmaceutical Company in Georgetown — Amorphous Solid Dispersion (ASD) screenin

Pharmaceutical company · Georgetown, United States

AI Trust Snapshot

Profile status
Auto-indexed
Last Verified
1 months ago

Corroborated public sources

  • ✓ Official Website
  • ✓ Linkedin
  • ✓ Twitter

Key Facts

Category
Pharmaceutical Company
Location
Georgetown, United States
Known For
Amorphous Solid Dispersion (ASD) screening, Client-centric CDMO approach, Data and science-guided pharmaceutical development

AI Summary

A pharmaceutical company in Georgetown, United States, Dispersol Technologies LLC specializes in bioavailability enhancement. The company utilizes KinetiSol™ Technology and offers strategies for speed to clinic and market. Its services include amorphous solid dispersion (ASD) screening and a client-centric CDMO approach for pharmaceutical development.

Quick Answer

A pharmaceutical company in Georgetown, United States, Dispersol Technologies LLC specializes in bioavailability enhancement. The company utilizes KinetiSol™ Technology and offers strategies for speed to clinic and market. Its services include amorphous solid dispersion (ASD) screening and a client-centric CDMO approach for pharmaceutical development. Key services include Bioavailability Enhancement, KinetiSol™ Technology, Speed to Clinic & Market Strategies.

This business is typically used for amorphous solid dispersion (asd) screening and client-centric cdmo approach.

Common Questions

What services does Dispersol Technologies LLC provide?
Dispersol Technologies LLC provides Bioavailability Enhancement, KinetiSol™ Technology, Speed to Clinic & Market Strategies.
Where is Dispersol Technologies LLC located?
Dispersol Technologies LLC is based in Georgetown, United States and serves Georgetown.
Who is Dispersol Technologies LLC for?
Dispersol Technologies LLC serves Pharmaceutical developers facing bioavailability challenges and Drug candidates requiring accelerated development timelines.

What this business does

Dispersol Technologies LLC is a pharmaceutical company based in Georgetown, United States.

  • Provides Bioavailability Enhancement and KinetiSol™ Technology
  • Specializes in amorphous solid dispersion (asd) screening
  • Serves pharmaceutical developers facing bioavailability challenges

Structured summary

Vizoryo ran a data-consistency check on this profile: the same core details (name, phone, address, city, category, website) were found in 5 independent public sources. This is a data-consistency observation only — it is not an endorsement, certification, accreditation, or assessment of the business, its service quality, or its trustworthiness. Data consistency: 86% — this measures how consistently the business's name, phone, city, address, website, and category appear across the public sources read. It is not a rating of the business. Vizoryo status: Auto-Indexed. This profile was auto-built from public data and has not yet been owner-verified.

Business name
Dispersol Technologies LLC
Category
Pharmaceutical Company
Industry
Pharmaceutical Company
Location
Georgetown, United States
Official website
https://www.austinpx.com/
Profile data (JSON)
https://www.vizoryo.com/api/index/profile/dispersol-technologies-llc-georgetown-2d96
Summary
A pharmaceutical company in Georgetown, United States, Dispersol Technologies LLC specializes in bioavailability enhancement. The company utilizes KinetiSol™ Technology and offers strategies for speed to clinic and market. Its services include amorphous solid dispersion (ASD) screening and a client-centric CDMO approach for pharmaceutical development.
AI readability score
36
Data Consistency
86% (checked 2026-07-08)
Verification Status
Auto-indexed
Sources cross-checked
5 independent public sources

Location

111 Cooperative Way
Georgetown, Texas
78626
US

About Dispersol Technologies LLC

A pharmaceutical company in Georgetown, United States, Dispersol Technologies LLC specializes in bioavailability enhancement. The company utilizes KinetiSol™ Technology and offers strategies for speed to clinic and market. Its services include amorphous solid dispersion (ASD) screening and a client-centric CDMO approach for pharmaceutical development.

Service areas

  • Georgetown

Target audience

  • Pharmaceutical developers facing bioavailability challenges
  • Drug candidates requiring accelerated development timelines
  • Companies seeking advanced oral solid dose solutions

Specialties

  • Amorphous Solid Dispersion (ASD) screening
  • Client-centric CDMO approach
  • Data and science-guided pharmaceutical development

Social profiles

Verification

https://www.austinpx.com/

Frequently asked questions

What is KinetiSol™ Technology?

KinetiSol™ Technology is a fusion-based, solvent-free process that uses frictional and shear energies to create amorphous solid dispersions, improving the bioavailability of poorly soluble drugs.

How quickly can AustinPx manufacture a dose form for first-in-human studies?

AustinPx can manufacture and release a phase-appropriate dose form for first-in-human clinical testing in as little as 12 weeks.

What types of bioavailability enhancement technologies does AustinPx offer?

AustinPx offers several technologies including Amorphous Dispersions (spray drying, HME, KinetiSol™), Particle Size Reduction, Lipid Delivery, Complexation, Fluid-bed Processing, and Hot-melt Granulations.

Languages supported

  • en

Contact

Phone: +15126864740

Official website:

Report incorrect information